A Phase II Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung
Phase of Trial: Phase II
Latest Information Update: 03 Jul 2018
At a glance
- Drugs Pazopanib (Primary)
- Indications Cancer metastases; Osteosarcoma
- Focus Therapeutic Use
- Sponsors Vector Oncology Solutions LLC
- 03 Jan 2018 Status changed from active, no longer recruiting to discontinued due to low accrual.
- 22 Nov 2017 Planned End Date changed from 1 Oct 2017 to 1 Jan 2018.
- 22 Nov 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Dec 2017.